Previous 10 | Next 10 |
home / stock / aqszf / aqszf news
Aequus Pharmaceuticals ( OTCQB:AQSZF ) signed an agreement for Canadian distribution rights to 10 products of Ireland-based Scope Ophthalmics' over-the-counter ophthalmology portfolio. The products include the Optase range of preservative free dry eye products, A...
Also reports Financial Results for the 3 months ended March 31, 2022 VANCOUVER, British Columbia, July 01, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a...
VANCOUVER, British Columbia, May 06, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS , OTCQB: AQSZF ) (“ Aequus ” or the “ Company ”) announces that further to its news release on May 2, 2022, the filing of its audited annual fina...
VANCOUVER, British Columbia, May 02, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS , OTCQB: AQSZF ) (“ Aequus ” or the “ Company ”) announces that the filing of its audited annual financial statements for the fiscal year ended D...
VANCOUVER, British Columbia, May 02, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS , OTCQB: AQSZF ) (“ Aequus ” or the “ Company ”) announces that it has entered into an agreement with Mr. Doug Janzen, Chairman and Chief Executi...
VANCOUVER, British Columbia, April 22, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, announces that Mr. Jason Flowerday has resigned from the Ae...
A lot has changed in the market since my last article on 07 Apr 2021. AQS is struggling to deliver what it announced for 2021 / 2022. I will sell my AQS shares and explain the Why in this article. At the same time, I’m rating the stock a "Hold" and will explain why I...
VANCOUVER, British Columbia, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS , OTCQB: AQSZF ) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on developing, advancing and promoting differe...
Health Canada Submission of Preservative-Free Prescription ‘Zimed PF’ Accepted for Screening VANCOUVER, British Columbia, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS , OTCQB: AQSZF ), ) (“Aequus” or the “Compan...
LOS ANGELES, CA / ACCESSWIRE / December 6, 2021 / The SNN Network Canada Virtual Event will take place on December 7-9, 2021, where 70 SmallCap, MicroCap and NanoCap public and private companies will be presenting via virtual webcast to a global investor audience. The SNN Network Canada Vir...
News, Short Squeeze, Breakout and More Instantly...
Aequus Pharmaceuticals Inc Company Name:
AQSZF Stock Symbol:
OTCMKTS Market:
Aequus Pharmaceuticals Inc Website:
(TheNewswire) VANCOUVER, May 09, 2024 – TheNewswire – Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company focused on bringing healthcare solutions to Canadians through licens...
(TheNewswire) VANCOUVER, BC. May 7, 2024 – TheNewswire – Aequus Pharmaceuticals Inc. (TSX-V: AQS , OTCQB: AQSZF ), ) (“Aequus” or the “Company”), a specialty pharmaceutical company, in resp...
(TheNewswire) VANCOUVER – TheNewswire - April 29, 2024 – Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company focused on bringing healthcare solutions to Canadians through lic...